From: An international survey on aminoglycoside practices in critically ill patients: the AMINO III study
Variables | n |
---|---|
Microbiological sample (n = 930) | 826 (89%) |
Number of pathogens identified (n = 511) |  |
 1 | 317 (62%) |
 2 | 121 (24%) |
 3 and more | 73 (14%) |
Pathogens (n = 798) |  |
 Gram-positive bacteria | 255 (32%) |
  Staphylococcus/S. aureus | 120 (15%)/84 (10.5%) |
  Streptococci | 64 (8%) |
  Enterococci | 67 (8.4%) |
 Gram-negative bacteria | 453 (58%) |
  Escherichia coli | 166 (21%) |
  Klebsiella spp. | 70 (8.8%) |
  Pseudomonas aeruginosa | 73 (9%) |
  Enterobacter spp. | 41 (5%) |
  Acinetobacter baumannii | 9 (1%) |
  Stenotrophomonas maltophila | 5 (0.6%) |
 Anaerobes bacteria | 24 (3%) |
 Fungi/Candida | 33 (4%)/31 (3.9%) |
Susceptibility testing (n = 322) |  |
 AG susceptibility categories (S/I/R) | 254 (79%)/14 (4%)/54 (17%) |